Effect of Early Treatment with Ivermectin among Patients with Covid-19

$ 20.50

4.9 (744) In stock

Eric Topol on X: Ivermectin: the largest randomized, double-blind trial yet conducted, with early treatment, indicates there is no difference compared with placebo. It doesn't work. Period. just published @NEJM

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial - ScienceDirect

Ivermectin COVID-19 Treatment Guidelines

Ivermectin and Rheumatoid Arthritis: Safety, COVID, and More

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)

Use of ivermectin and factors associated with the

Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection

Systematic review and meta-analysis of ivermectin for treatment of COVID-19: evidence beyond the hype, BMC Infectious Diseases

Study: Ivermectin does not prevent COVID-19 hospitalization

Ivermectin as empiric treatment for Strongyloides in patients with COVID-19, CCDR 47(7/8)

Ivermectin: South African medics using unproven worm drug to treat Covid-19